Real-oWorld Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation

被引：0
|
作者：
Yan, Vincent K. C. [1 ]
Yu, Yang [1 ]
Wan, Eric Y. F. [2 ,3 ]
Wong, Ian Chi Kei [1 ]
Chan, Esther W. [1 ]
机构：
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Peoples R China
[2] Univ Hong Kong, Li Ka Shing Fac Med, Dept Family Med & Primary Care, Hong Kong, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Peoples R China
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
496
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD EFFECTIVENESS AND SAFETY OF TIXAGEVIMAB-CILGAVIMAB: A TARGET TRIAL EMULATION STUDY
    Yan, V
    Yang, Y.
    Wan, E. Y. F.
    Yiu, H. H. E.
    Wong, I. C. K.
    Chan, E. W.
    VALUE IN HEALTH, 2023, 26 (12) : S221 - S221
  • [2] Real-World Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation Study
    Yan, Vincent Ka Chun
    Yang, Yu
    Wan, Eric Yuk Fai
    Lai, Francisco Tsz Tsun
    Chui, Celine Sze Ling
    Li, Xue
    Wong, Carlos King Ho
    Hung, Ivan Fan Ngai
    Lau, Chak Sing
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    DRUG SAFETY, 2024, 47 (10) : 1025 - 1037
  • [3] Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence
    Altieri, Manuela
    Melisi, Rosario Domenico
    Conte, Miriana
    Capuano, Rocco
    Donnarumma, Giovanna
    Grimaldi, Elena
    Coppola, Nicola
    De Pascalis, Stefania
    Risi, Mario
    d'Ambrosio, Alessandro
    Bisecco, Alvino
    Gallo, Antonio
    NEUROLOGICAL SCIENCES, 2023, 44 (11) : 4107 - 4110
  • [4] Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence
    Manuela Altieri
    Rosario Domenico Melisi
    Miriana Conte
    Rocco Capuano
    Giovanna Donnarumma
    Elena Grimaldi
    Nicola Coppola
    Stefania De Pascalis
    Mario Risi
    Alessandro d’Ambrosio
    Alvino Bisecco
    Antonio Gallo
    Neurological Sciences, 2023, 44 : 4107 - 4110
  • [5] Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era
    Chen, Benjamin
    Haste, Nina
    Binkin, Nancy
    Law, Nancy
    Horton, Lucy E. E.
    Yam, Nancy
    Chen, Victor
    Abeles, Shira
    PLOS ONE, 2023, 18 (04):
  • [6] Real-world effectiveness of prophylactic tixagevimab-cilgavimab monoclonal antibodies on incidence and severity of COVID-19 infection in patients with cancer
    Naser, Maryam
    Bhardwaj, Prarthna V.
    Warriach, Fatima Zahid
    Jadoon, Yamna
    Gupta, Kush
    Rastegar, Vida
    Loke, Chandravathi
    Malleshappa, Sudeep Kumar Siddappa
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions
    Duminuco, Andrea
    Nardo, Antonella
    Orofino, Alessandra
    Giunta, Giuliana
    Conticello, Concetta
    Del Fabro, Vittorio
    Chiarenza, Annalisa
    Parisi, Marina S.
    Figuera, Amalia
    Leotta, Salvatore
    Milone, Giuseppe
    Cupri, Alessandra
    Cambria, Daniela
    Di Raimondo, Francesco
    Romano, Alessandra
    Palumbo, Giuseppe A.
    CANCER, 2024, 130 (01) : 41 - 50
  • [8] Breakthrough SARS-CoV-2 infections among recipients of tixagevimab-cilgavimab prophylaxis: A citywide real-world effectiveness study
    Lendacki, Frances R.
    Li, Linda
    Forrest, Graeme N.
    Jordan, Leirah
    Zelinski, Christy
    Black, Stephanie R.
    Ison, Michael G.
    Seo, Jennifer Y.
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [9] Safety of intramuscular tixagevimab-cilgavimab (Evusheld®) administration in patients at risk of iatrogenic haematoma due to haematological disorders
    Malherbe, Jacques A. J.
    Misko, Jeanie
    Jayawardena, Nishani K.
    Rawlins, Matthew D. M.
    Manning, Laurens
    Purtill, Duncan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [10] Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies
    Ocon, Anthony J.
    Ocon, Kate E.
    Battaglia, Jennifer
    Low, Soon Khai
    Neupane, Niraj
    Saeed, Hasseen
    Jamshed, Saad
    Mustafa, S. Shahzad
    JOURNAL OF HEMATOLOGY, 2022, 11 (06) : 210 - 215
12345